0
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found

      Role of the Cardiac Conduction System in Determining the QRS Amplitude after Bleeding

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The QRS complex in the ECG of poikilotherms is increased by bleeding. The opposite reaction is observed in homeotherms. In previous studies, the type of QRS response to hemorrhage and infusion was ascribed to a phylogenetic difference, namely the presence or absence of a specialized conduction system in the heart. In order to substantiate the role of the specialized conducting system, two mammalian preparations were designed using the same species (cat) under conditions allowing both specialized conduction and cell-to-cell conduction. Comparison of the changes observed during bleeding or transfusion in the R’ wave of cats with bundle branch block, and in the depolarization wave obtained by ventricular pacing (both of which mimic poikilotherm conduction), with the changes in the R wave in normal cats, clearly show the dependence of the changes in QRS amplitude on the type of conduction system in the heart.

          Related collections

          Author and article information

          Journal
          CRD
          Cardiology
          10.1159/issn.0008-6312
          Cardiology
          S. Karger AG
          0008-6312
          1421-9751
          1974
          1974
          29 October 2008
          : 59
          : 3
          : 162-171
          Affiliations
          Department of Physiology and Pharmacology, Tel Aviv, University, Sackler School of Medicine, Beilinson Hospital, Petah Tikva and Institute for Cardiovascular Diseases, Tokyo Medical and Dental University, Tokyo
          Article
          169674 Cardiology 1974;59:162–171
          10.1159/000169674
          4447952
          © 1974 S. Karger AG, Basel

          Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

          Page count
          Pages: 10
          Categories
          Paper

          Comments

          Comment on this article